Cargando…
Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling
INTRODUCTION: Metabolic profiling of cerebrospinal fluid (CSF) is a promising technique for studying brain diseases. Measurements should reflect the in vivo situation, so ex vivo metabolism should be avoided. OBJECTIVE: To investigate the effects of temperature (room temperature vs. 4 °C), centrifug...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838118/ https://www.ncbi.nlm.nih.gov/pubmed/29527143 http://dx.doi.org/10.1007/s11306-018-1333-0 |
_version_ | 1783304188895166464 |
---|---|
author | Noga, Marek J. Zielman, Ronald van Dongen, Robin M. Bos, Sabine Harms, Amy Terwindt, Gisela M. van den Maagdenberg, Arn M. J. M. Hankemeier, Thomas Ferrari, Michel D. |
author_facet | Noga, Marek J. Zielman, Ronald van Dongen, Robin M. Bos, Sabine Harms, Amy Terwindt, Gisela M. van den Maagdenberg, Arn M. J. M. Hankemeier, Thomas Ferrari, Michel D. |
author_sort | Noga, Marek J. |
collection | PubMed |
description | INTRODUCTION: Metabolic profiling of cerebrospinal fluid (CSF) is a promising technique for studying brain diseases. Measurements should reflect the in vivo situation, so ex vivo metabolism should be avoided. OBJECTIVE: To investigate the effects of temperature (room temperature vs. 4 °C), centrifugation and ethanol, as anti-enzymatic additive during CSF sampling on concentrations of glutamic acid, glutamine and other endogenous amines. METHODS: CSF samples from 21 individuals were processed using five different protocols. Isotopically-labeled alanine, isoleucine, glutamine, glutamic acid and dopamine were added prior to sampling to trace any degradation. Metabolomics analysis of endogenous amines, isotopically-labeled compounds and degradation products was performed with a validated LC–MS method. RESULTS: Thirty-six endogenous amines were quantified. There were no statistically significant differences between sampling protocols for 31 out of 36 amines. For GABA there was primarily an effect of temperature (higher concentrations at room temperature than at 4 °C) and a small effect of ethanol (lower concentrations if added) due to possible degradation. O-phosphoethanolamine concentrations were also lower when ethanol was added. Degradation of isotopically-labeled compounds (e.g. glutamine to glutamic acid) was minor with no differences between protocols. CONCLUSION: Most amines can be considered stable during sampling, provided that samples are cooled immediately to 4 °C, centrifuged, and stored at − 80 °C within 2 h. The effect of ethanol addition for more unstable metabolites needs further investigation. This was the first time that labeled compounds were used to monitor ex vivo metabolism during sampling. This is a useful strategy to study the stability of other metabolites of interest. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11306-018-1333-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5838118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-58381182018-03-09 Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling Noga, Marek J. Zielman, Ronald van Dongen, Robin M. Bos, Sabine Harms, Amy Terwindt, Gisela M. van den Maagdenberg, Arn M. J. M. Hankemeier, Thomas Ferrari, Michel D. Metabolomics Original Article INTRODUCTION: Metabolic profiling of cerebrospinal fluid (CSF) is a promising technique for studying brain diseases. Measurements should reflect the in vivo situation, so ex vivo metabolism should be avoided. OBJECTIVE: To investigate the effects of temperature (room temperature vs. 4 °C), centrifugation and ethanol, as anti-enzymatic additive during CSF sampling on concentrations of glutamic acid, glutamine and other endogenous amines. METHODS: CSF samples from 21 individuals were processed using five different protocols. Isotopically-labeled alanine, isoleucine, glutamine, glutamic acid and dopamine were added prior to sampling to trace any degradation. Metabolomics analysis of endogenous amines, isotopically-labeled compounds and degradation products was performed with a validated LC–MS method. RESULTS: Thirty-six endogenous amines were quantified. There were no statistically significant differences between sampling protocols for 31 out of 36 amines. For GABA there was primarily an effect of temperature (higher concentrations at room temperature than at 4 °C) and a small effect of ethanol (lower concentrations if added) due to possible degradation. O-phosphoethanolamine concentrations were also lower when ethanol was added. Degradation of isotopically-labeled compounds (e.g. glutamine to glutamic acid) was minor with no differences between protocols. CONCLUSION: Most amines can be considered stable during sampling, provided that samples are cooled immediately to 4 °C, centrifuged, and stored at − 80 °C within 2 h. The effect of ethanol addition for more unstable metabolites needs further investigation. This was the first time that labeled compounds were used to monitor ex vivo metabolism during sampling. This is a useful strategy to study the stability of other metabolites of interest. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11306-018-1333-0) contains supplementary material, which is available to authorized users. Springer US 2018-03-05 2018 /pmc/articles/PMC5838118/ /pubmed/29527143 http://dx.doi.org/10.1007/s11306-018-1333-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Noga, Marek J. Zielman, Ronald van Dongen, Robin M. Bos, Sabine Harms, Amy Terwindt, Gisela M. van den Maagdenberg, Arn M. J. M. Hankemeier, Thomas Ferrari, Michel D. Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling |
title | Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling |
title_full | Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling |
title_fullStr | Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling |
title_full_unstemmed | Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling |
title_short | Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling |
title_sort | strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838118/ https://www.ncbi.nlm.nih.gov/pubmed/29527143 http://dx.doi.org/10.1007/s11306-018-1333-0 |
work_keys_str_mv | AT nogamarekj strategiestoassessandoptimizestabilityofendogenousaminesduringcerebrospinalfluidsampling AT zielmanronald strategiestoassessandoptimizestabilityofendogenousaminesduringcerebrospinalfluidsampling AT vandongenrobinm strategiestoassessandoptimizestabilityofendogenousaminesduringcerebrospinalfluidsampling AT bossabine strategiestoassessandoptimizestabilityofendogenousaminesduringcerebrospinalfluidsampling AT harmsamy strategiestoassessandoptimizestabilityofendogenousaminesduringcerebrospinalfluidsampling AT terwindtgiselam strategiestoassessandoptimizestabilityofendogenousaminesduringcerebrospinalfluidsampling AT vandenmaagdenbergarnmjm strategiestoassessandoptimizestabilityofendogenousaminesduringcerebrospinalfluidsampling AT hankemeierthomas strategiestoassessandoptimizestabilityofendogenousaminesduringcerebrospinalfluidsampling AT ferrarimicheld strategiestoassessandoptimizestabilityofendogenousaminesduringcerebrospinalfluidsampling |